Amazon Launches AWS for Health, Joins Google Cloud and Microsoft Cloud for Healthcare in Effort to Streamline Drug Development
Amazon is the latest company to enter the cloud-based healthcare space. It recently launched Amazon Web Services (AWS) for Health. [...]
Costly Oncology Drugs Face ICER Scrutiny and Calls for Value-Based Pricing
Novel drugs used in cancer treatment, including chimeric antigen receptor (CAR)-T cell therapies, are increasing in popularity. However, their cost [...]
Wyden’s Principles of Reform Include a US-Based Drug Pricing System
Senator Wyden is pushing for legislation that will reduce prescription drug prices, such as Biogen’s pricy Aduhelm. He’s noted that [...]
10-Year Hydrocortisone Tablet Overcharge and Pay-For-Delay Deal Lead to £266.4 Million in Fines
The UK Competition and Markets Authority (CMA) has fined hydrocortisone tablet manufacturers £266.4 million for overcharging the National Health Service [...]
New ISPOR Article Discusses Survey on the Impact of COVID-19 on HTAs and Payers
A new article, published in ISPOR’s Value in Health journal, discusses how the COVID-19 pandemic has impacted health technology assessments [...]
Biogen Controversy Highlights FDA’s Rules Surrounding Expert Panels
The Food and Drug Administration (FDA)’s approval of Biogen’s Aduhelm was based on shaky data. The resulting controversy continues to [...]
Democrats and Republicans Unite in Pushing for Medicare Negotiation Legislation, Could Save $500 Billion
Bipartisan support is building for legislative mechanisms that would lead to reduced healthcare costs in the United States. One key [...]
Why Are Drug Manufacturers Disregarding Clinical Trial Transparency Regulations?
A recent study found that most pharmaceutical companies do not meet rules demanding transparency in clinical trials. This lack of [...]
Winners Announced for IMD’s Career Cluster Day Case Competition
Clinerion recently hosted a case competition highlighting the use of real world data (RWD) in healthcare. Students considered the many [...]
Amazon Launches AWS for Health and Amazon HealthLake Data Analysis Tool
Amazon has announced the launch of AWS for Health, which will partner with pharma and healthcare organizations and offer a [...]
Specialty Pharmacy Needs Greater Transparency and Equity to Avoid Federal Surveillance
According to Informa Connect’s recent meeting on specialty pharma, increased transparency is needed to avoid headaches stemming from federal surveillance [...]
HealthVerity Discusses COVID-19, Booster Vaccines, and RWD
As variants of the COVID-19 virus emerge, included the concerning delta variant, pharmaceutical companies are suggesting that a booster shot [...]
New Report Notes 65 Prescription Drug Increases in July 2021, 800 in January
65 drugs have increased in price this month by approximately 3.5%. GoodRx identified drug manufacturers, which include Pfizer, Bristol Myers [...]
Cigna Incentive Program Offers $500 to Switch from Biologics to Biosimilars, Drug Savings Could Reach $375 Billion
In an effort to promote biosimilars, Cigna is offering $500 if customers switch to a lower-cost offering. Experts project that [...]
2021 Managed Healthcare Executive Pharmacy Survey Respondents Consider Impact of Federal Legislation on Drug Prices
The final portion of Managed Healthcare Executive’s 2021 Pharmacy Survey focused on federal legislation as a mechanism to reduce prescription [...]
Which Factors Drive Specialty Drug Expenditures?
The Managed Healthcare Executive Pharmacy Survey asked respondents questions related to specialty drug expenditures in 2021. Most of the 225 [...]
Prescription Drug Prices Increased 3.1% in July 2020 According to GoodRx
GoodRx found that 52 drugs rose in price by 3.1% in July 2020, while no generics upped their prices. Zogenix’s [...]
Vanderbilt and Stanford Professors Discuss 2021 Drug Pricing Reform in JAMA Article, Note Power of Value Assessments and Medicare Negotiation During COVID-19 Pandemic
Dr. Stacie Dusetzina of Vanderbilt University School of Medicine and Dr. Michelle Mello of Stanford Law School and Stanford School [...]
ICER Considers Fair Access Principles as Aduhelm Price Continues to Incense Critics
The Institute for Clinical and Economic Review (ICER) recently published its protocol detailing how it will gauge access to prescription [...]
2021 Managed Healthcare Executive Pharmacy Survey Results Include Increased Focus on Price Transparency to Reduce Prescription Drug Costs
Managed Healthcare Executive is publishing the results from its recent survey. According to the more than 225 respondents, reducing drug [...]
GoodRx Study Finds 6,000 Percent Hospital Chargemaster Upcharge for Generic Drugs
GoodRx recently assessed the prices of 12 generic drugs across healthcare systems in the United States. Prices varied widely, with [...]
CVS Eliminates 72 Hyperinflated Drugs, Saving $1.2 Billion in 2020
CVS has removed 72 high-priced drugs from its formulary. This move has led to $1.2 billion in savings last year [...]
New Report Examines Generic Drug Uptake Trends and Impact on Healthcare Costs
ISPOR’s Value in Health journal recently published an article examining generic drug uptake trends in the United States. Researchers assessed [...]
Wednesday Webinar on Strategic Healthcare Data Usage, COVID-19 Impact, and Health Equity Strategies for Employers
Register today for a webinar hosted by the Integrated Benefits Institute (IBI) and Purchaser Business Group on Health (PBGH). It [...]
Register today for ISPOR Short Course on Implementing Risk-Sharing Arrangement for Therapeutics and Medical Devices
ISPOR will host a short course on June 29th and 30th from 10:00 AM – 12:00 PM EDT each day. [...]